198 related articles for article (PubMed ID: 8685035)
1. Stereological evaluation of malignant mesothelioma versus benign pleural hyperplasia.
Bogers J; Jacobs W; Segers K; Van Daele A; Weyler J; Van Marck E
Pathol Res Pract; 1996 Jan; 192(1):10-4. PubMed ID: 8685035
[TBL] [Abstract][Full Text] [Related]
2. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
Cury PM; Butcher DN; Corrin B; Nicholson AG
J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
[TBL] [Abstract][Full Text] [Related]
3. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.
Soosay GN; Griffiths M; Papadaki L; Happerfield L; Bobrow L
J Pathol; 1991 Apr; 163(4):299-305. PubMed ID: 2033489
[TBL] [Abstract][Full Text] [Related]
4. [Malignant mesothelioma of the pleura. Morphometric study].
Serio G; Caniglia DM; Pennella A; Giardina C; Dalena AM; Serio R; Lettini T; Ricco R
Pathologica; 1997 Apr; 89(2):122-7. PubMed ID: 9411357
[TBL] [Abstract][Full Text] [Related]
5. p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections.
Mayall FG; Goddard H; Gibbs AR
J Pathol; 1992 Dec; 168(4):377-81. PubMed ID: 1484319
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural diagnosis of pleural tumors.
Stoebner P; Brambilla E
Pathol Res Pract; 1982; 173(4):402-16. PubMed ID: 6889732
[TBL] [Abstract][Full Text] [Related]
7. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
8. [Mesothelioma of the pleura--diagnosis with imaging procedures].
Layer G; van Kaick G
Langenbecks Arch Chir Suppl Kongressbd; 1992; ():173-9. PubMed ID: 1493266
[TBL] [Abstract][Full Text] [Related]
9. Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.
Henderson DW; Reid G; Kao SC; van Zandwijk N; Klebe S
J Clin Pathol; 2013 Oct; 66(10):847-53. PubMed ID: 23814259
[TBL] [Abstract][Full Text] [Related]
10. Benign and malignant mesothelial lesions of the pleura: quantitative study.
Ranaldi R; Marinelli F; Barbatelli G; Mariuzzi G; Marzocchi F; Mancini AM; Pisani E; Ansuini G; Ricci M
Appl Pathol; 1986; 4(1-2):55-64. PubMed ID: 3580194
[TBL] [Abstract][Full Text] [Related]
11. [Ultrastructural diagnostic problems of pleural tumors. A study of 125 cases (author's transl)].
Stoebner P; Bernaudin JF; Adnet JJ; Basset F
Rev Fr Mal Respir; 1979; 7(3):265-76. PubMed ID: 573917
[TBL] [Abstract][Full Text] [Related]
12. [Detection of p16 by fluorescence in-situ hybridization and immunohistochemistry in malignant mesothelioma].
Liu Y; Chen X; Ding N; Xu W; Yang H; Chen X
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):262-5. PubMed ID: 25975910
[TBL] [Abstract][Full Text] [Related]
13. [Malignant mesothelioma of the pleura--diagnostic difficulties].
Drozdowska A; Damps-Konstańska I; Kobierska-Gulida G; Madrzak J; Kuziemski K; Pieńkowska J; Ucińska R; Słomiński JM
Pol Merkur Lekarski; 2004 Oct; 17(100):380-1. PubMed ID: 15690708
[TBL] [Abstract][Full Text] [Related]
14. Computerized interactive morphometry. A study of malignant mesothelioma and mesothelial hyperplasia in pleural biopsy specimens.
Marchevsky AM; Gil J; Caccamo D
Arch Pathol Lab Med; 1985 Dec; 109(12):1102-5. PubMed ID: 3840984
[TBL] [Abstract][Full Text] [Related]
15. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
16. β-catenin expression in benign and malignant pleural disorders.
Anani W; Bruggeman R; Zander DS
Int J Clin Exp Pathol; 2011; 4(8):742-7. PubMed ID: 22135721
[TBL] [Abstract][Full Text] [Related]
17. [Chronic pleuropathy due to asbestos and malignant mesothelioma of the pleura: a differential diagnosis not always easy. A case report].
de Pangher Manzini V
Recenti Prog Med; 1999 Jun; 90(6):331-3. PubMed ID: 10399473
[TBL] [Abstract][Full Text] [Related]
18. [Large-cell carcinoma presenting as diffuse thickening of the pleura and resembling malignant mesothelioma].
Nakamura H; Ikeda I; Nakahama H; Kitada O; Sugita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):451-4. PubMed ID: 9212673
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach.
Kradin RL; Mark EJ
Semin Diagn Pathol; 2006 Feb; 23(1):4-14. PubMed ID: 17044190
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid analysis and the diagnosis of pleural mesothelioma.
Boersma A; Degand P; Biserte G
Bull Eur Physiopathol Respir; 1980; 16(1):41-5. PubMed ID: 7357125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
